CR8030A - TRANSDERMAL DOSE RESISTANT TO INTERFERENCES, INCLUDING AN ACTIVE AGENT COMPONENT AND AN HARMFUL AGENT COMPONENT ON THE DISTAL AGENT LAYER SITE - Google Patents
TRANSDERMAL DOSE RESISTANT TO INTERFERENCES, INCLUDING AN ACTIVE AGENT COMPONENT AND AN HARMFUL AGENT COMPONENT ON THE DISTAL AGENT LAYER SITEInfo
- Publication number
- CR8030A CR8030A CR8030A CR8030A CR8030A CR 8030 A CR8030 A CR 8030A CR 8030 A CR8030 A CR 8030A CR 8030 A CR8030 A CR 8030A CR 8030 A CR8030 A CR 8030A
- Authority
- CR
- Costa Rica
- Prior art keywords
- agent component
- component
- distal
- interferences
- active agent
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere a una forma de dosificacion transdermica que comprende un componente que contiene un agente activo que posee una superficie proxima y una superficie distal y un componente que contiene un agente adverso ubicado de manera distal al componente de agente activo en el que el componente de agente activo define al menos un canal que se extiende sustancialmente desde la superficie proxima a la superficie distal.The present invention relates to a transdermal dosage form comprising a component that contains an active agent that has a proximal surface and a distal surface and a component that contains an adverse agent located distally to the active agent component in which the Active agent component defines at least one channel that extends substantially from the surface proximal to the distal surface.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46723503P | 2003-04-30 | 2003-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8030A true CR8030A (en) | 2007-10-22 |
Family
ID=36770597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8030A CR8030A (en) | 2003-04-30 | 2005-10-05 | TRANSDERMAL DOSE RESISTANT TO INTERFERENCES, INCLUDING AN ACTIVE AGENT COMPONENT AND AN HARMFUL AGENT COMPONENT ON THE DISTAL AGENT LAYER SITE |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1780611B (en) |
CR (1) | CR8030A (en) |
ZA (1) | ZA200507862B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102068697B (en) * | 2010-12-30 | 2013-10-16 | 宜昌人福药业有限责任公司 | Opiates painkiller and opiate receptor antagonist-containing medicinal composition |
RU2700926C2 (en) * | 2014-01-22 | 2019-09-24 | 4П Терапьютикс | Transdermal systems preventing abuse and misuse |
GB201513442D0 (en) * | 2015-07-30 | 2015-09-16 | Euro Celtique Sa | Transdermal patch |
KR102279552B1 (en) * | 2016-12-28 | 2021-07-19 | 히사미쓰 세이야꾸 가부시키가이샤 | Patches containing butorphanol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149538A (en) * | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
-
2004
- 2004-04-30 CN CN200480011691.XA patent/CN1780611B/en not_active Expired - Fee Related
-
2005
- 2005-09-28 ZA ZA200507862A patent/ZA200507862B/en unknown
- 2005-10-05 CR CR8030A patent/CR8030A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200507862B (en) | 2006-06-28 |
CN1780611B (en) | 2013-01-30 |
CN1780611A (en) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP056191A (en) | MANIFULATION RESISTANT TRANSDERMAL DOSAGE FORM INCLUDING AN ACTIVE AGENT COMPONENT AND AN ADVERSE AGENT COMPONENT ON THE DISTAL SURFACE OF THE LAYER OF THE ACTIVE AGENT | |
CY1121330T1 (en) | COMPOSITIONS CONTAINING AZELASTIN AND METHODS OF USING THEM | |
ECSP088208A (en) | NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
CY1121593T1 (en) | TETRAHYDROCANNAVINOL PRODUCTS, COMPOSITIONS INCLUDING TETRAHYDROCANNAVINOL PRODUCTS AND METHODS FOR USING THE SAME | |
SV2007002146A (en) | DIFENYLIMIDAZOPIRIMIDINE AND IMIDAZOL AMINAS AS BETA-SECRETASA INHIBITORS REF. AM101727 | |
UY30158A1 (en) | USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT | |
ATE355065T1 (en) | THERAPEUTIC COMPOSITIONS CONSISTING OF ANTIHYPOTENSIVES AND ANTIANGIOGENICS | |
AR055838A1 (en) | FORMULATIONS FOR COVERED MICROPROJECTIONS THAT HAVE CONTROLLED SOLUBILITY | |
AR054227A1 (en) | COMPOSITION OF ACTIVE PRINCIPLES | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
NI200800169A (en) | USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF PAIN | |
ATE540690T1 (en) | INSULIN COMBINATIONS | |
SI1973539T1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
ECSP066878A (en) | [HYDROCHLORIDE OF [4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL] - (4-BROMO-3-METHYL-5-PROPOXI-THIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE TRIPTASE | |
ES2250416T3 (en) | STIMULANT OF SECRECIOHN OF HORMONE OF GROWTH. | |
MX2010005012A (en) | Compositions for the treatment and prevention of eyelid swelling. | |
CL2007002875A1 (en) | Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms. | |
DK1680128T3 (en) | Myo-inositol hexaphosphate for topical use | |
AR057876A1 (en) | TREATMENT OF PATIENTS WITH CHRONIC RENAL DISEASE (ERC) USING COMPOUNDS OF THE INVENTION | |
CR8030A (en) | TRANSDERMAL DOSE RESISTANT TO INTERFERENCES, INCLUDING AN ACTIVE AGENT COMPONENT AND AN HARMFUL AGENT COMPONENT ON THE DISTAL AGENT LAYER SITE | |
CY1114760T1 (en) | Atherosclerosis Therapeutic Treatment | |
PA8651401A1 (en) | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE | |
AR026911A1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF TUMOR AFFECTIONS | |
PA8549401A1 (en) | COMPLEX THAT INCLUDES INHIBITING FACTOR OF OSTEOCLASTOGENESIS AND POLISACARIDO | |
CL2004000767A1 (en) | ORAL DOSING UNIT INCLUDING AN ANTAGONIST AGENT FOR PUMPS OF PROTONS AND EXCIPIENTS OF BASIC CHARACTER; PROCEDURE FOR PREPARATION, USEFUL TO TREAT DISEASES CAUSED BY AN INCREASED SECRETION OF GASTRIC ACIDS. |